Literature DB >> 30279879

Successful alcohol septal ablation in a pregnant patient with symptomatic hypertrophic obstructive cardiomyopathy.

Armaan Shaikh1, Tanvir Bajwa1, Michelle Bush1, A Jamil Tajik1.   

Abstract

Hypertrophic cardiomyopathy is a clinically heterogeneous disease with common findings of ventricular hypertrophy, left ventricular outflow tract (LVOT) obstruction, mitral regurgitation, and diastolic dysfunction. Sometimes, the condition can lead to catastrophic cardiac events. Pregnancy can pose a larger challenge, due to medication restrictions associated with pregnancy. We report a case of a 43-year-old pregnant woman presenting with symptomatic hypertrophic obstructive cardiomyopathy (HOCM). As her pregnancy progressed, her HOCM worsened both symptomatically and by objective echocardiographic data. These changes continued despite optimized medical therapy. After an in-depth discussion with both the patient and family, we proceeded with alcohol septal ablation, which was successful in both reducing her LVOT gradient and her symptoms. Her pregnancy was overall uneventful, and both she and her child are doing well more than 4 years from the date of the procedure. <Learning objective: While medical therapy is the first-line approach to patients with hypertrophic cardiomyopathy (HCM), symptoms may still persist despite optimized medical therapy. If medical therapy fails in a pregnant patient with symptomatic HCM and a significant left ventricular outflow tract gradient, successful alcohol septal ablation can improve the gradient and relieve symptoms.>.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Pregnancy; Septal ablation

Year:  2018        PMID: 30279879      PMCID: PMC6149578          DOI: 10.1016/j.jccase.2017.12.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  3 in total

1.  Reducing ionizing radiation doses during cardiac interventions in pregnant women.

Authors:  Elizabeth Orchard; Sarah Dix; Neil Wilson; Lucy Mackillop; Oliver Ormerod
Journal:  Obstet Med       Date:  2012-07-24

2.  Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.

Authors:  Jonathan N Johnson; Camilla Grifoni; J Martijn Bos; Maha Saber-Ayad; Steve R Ommen; Stefano Nistri; Franco Cecchi; Iacopo Olivotto; Michael J Ackerman
Journal:  Eur Heart J       Date:  2011-02-22       Impact factor: 29.983

3.  Outcomes of Alcohol Septal Ablation in Younger Patients With Obstructive Hypertrophic Cardiomyopathy.

Authors:  Max Liebregts; Lothar Faber; Morten K Jensen; Pieter A Vriesendorp; Jaroslav Januska; Jan Krejci; Peter R Hansen; Hubert Seggewiss; Dieter Horstkotte; Radka Adlova; Henning Bundgaard; Jurriën M Ten Berg; Josef Veselka
Journal:  JACC Cardiovasc Interv       Date:  2017-06-12       Impact factor: 11.195

  3 in total
  1 in total

1.  Management and outcome of hypertrophic obstructive cardiomyopathy in pregnant women: a case report.

Authors:  Maryem Assamti; Ramia Bougrine; Nabila Ismaili; Noha El Ouafi
Journal:  Pan Afr Med J       Date:  2021-02-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.